Neoplasm
RecruitingLong‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors
Greece- Participants:18–64 years · 65+ years
- Substances:Adagrasib
- Sponsor:Bristol-Myers Squibb Services Unlimited Company
Rare diseases
Investigational molecules
Locations
Back to Greece681 clinical trials in Thessaloniki, Greece across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Greece
Greece
Greece
Greece
Greece
Greece
Greece
Greece
Greece
Greece
Greece
GreeceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on head and neck squamous cell carcinoma, multiple myeloma, and advanced malignancies. Research includes innovative treatments for bladder cancer and gastrointestinal tumors.
Investigations emphasize improving survival outcomes and treatment efficacy.
Clinical trials addressing various autoimmune disorders including cutaneous lupus erythematosus, systemic sclerosis, and Sjögren's Syndrome. Studies evaluate new biologics and targeted therapies.
Research focuses on developing more effective treatments with improved safety profiles.
Comprehensive studies on Type 1 Diabetes and obesity, investigating novel therapeutic approaches. Trials examine treatments for weight management and glycemic control.
Research aims to improve patient outcomes through innovative treatment combinations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.